| Serial Number | 97331598 |
| Word Mark | JAMES P. ALLISON INSTITUTE |
| Filing Date | Friday, March 25, 2022 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Monday, September 30, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 6, 2024 |
| Goods and Services | (Based on Intent to Use) Educational services, namely, conducting programs, seminars, lectures and workshops in the fields of science and medicine relating to immunobiology, immunotherapy, wellness, cancer, diseases, and disease prevention and management; educational services, namely, developing and disseminating educational materials for others in the fields of science and medicine relating to immunobiology, immunotherapy, wellness, cancer, diseases, and disease prevention and management; arranging and conducting of training courses concerning research and development in the fields of cancer, autoimmune diseases, immunobiology and immunotherapy |
| Goods and Services | (Based on Use in Commerce) Charitable fundraising services |
| Goods and Services | (Based on Intent to Use) Promoting collaboration within the scientific, research, pharmaceutical, and medical communities to achieve advances in healthcare, including to accelerate the development and use of immunotherapy in treatment of disease |
| Goods and Services | (Based on Intent to Use) Providing patient advocate services in the treatment of diseases and disorders utilizing immunotherapy |
| Goods and Services | (Based on Intent to Use) Medical services; Dispensing of pharmaceuticals; Medical and pharmaceutical consultation; Medical services relating to cancer; Dispensing of pharmaceuticals relating to cancer; immunobiology and immunotherapy medical services; medical services, namely, the treatment of cancer, disease management, disease prevention and early detection, standardized diagnosis, staging and treatment, care and care assessment, medical counseling; medical consulting services, namely, consulting on the treatment of cancer, disease management, disease prevention and early detection, standardized diagnosis, staging and treatment, care and care assessment, and patient care management; providing medical information; providing health information in the field of immunobiology, immunotherapy, oncology and diseases; providing a web site featuring medical information; providing a web site featuring health information in the field of immunobiology, immunotherapy, oncology and diseases; providing medical information, consultancy and advisory services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, medical diagnostic testing, monitoring and reporting services; providing information on health care via a telephone and the internet; providing information on cancer treatment; medical services, namely, treatment in the field of oncology and related health problems and diseases; providing medical information to patients and medical professionals in the field of immunotherapy and cancer treatment; medical analysis services, namely, analysis of tumors, cancer or equivalent medical conditions |
| NOT AVAILABLE | "INSTITUTE" |
| Goods and Services | (Based on Use in Commerce) Medical research services; medical research, development, technical design, testing, and analysis services in the field of immunobiology, immunotherapy, antibodies, and oncology; consulting services in the fields of immunobiology, immunotherapy, antibodies, and oncology research, development, testing, analysis and data; medical research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; medical research services in the field of immune repertoire analysis and the genome; scientific research in the fields of immunobiology, immunotherapy, antibodies and oncology; biological research; laboratory research services in the fields of immunobiology, immunotherapy, antibodies, oncology, and cellular engineering; medical laboratory services; providing information on medical and scientific research in the field of immunobiology and immunotherapy; medical and scientific research for others in the field of stem cell research, cancer, immunobiology and immunotherapy; compiling data for research purposes in the field of medical science and medical consultancy; medical and scientific research liaison services, namely, consulting in the field of scientific research pertaining to clinical trials in the fields of health care, medicine, immunobiology, immunotherapy, pharmacology and biotechnology; collection and management of medical and scientific data for research purposes in the field of medical and scientific research; pharmaceutical research services; pharmaceutical research services relating to cancer |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 30, 2022 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 30, 2022 |
| Primary Code | 036 |
| First Use Anywhere Date | Thursday, March 24, 2022 |
| First Use In Commerce Date | Thursday, March 24, 2022 |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 30, 2022 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 30, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, March 24, 2022 |
| First Use In Commerce Date | Thursday, March 24, 2022 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 30, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 30, 2022 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | The Board of Regents of the University of Texas System |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 14 - State Agency |
| Address | Austin, TX 78701 |
| Party Name | The Board of Regents of the University of Texas System |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 14 - State Agency |
| Address | Austin, TX 78701 |
| Event Date | Event Description |
| Tuesday, March 29, 2022 | NEW APPLICATION ENTERED |
| Wednesday, March 30, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, August 25, 2022 | ASSIGNED TO EXAMINER |
| Monday, August 29, 2022 | NON-FINAL ACTION WRITTEN |
| Monday, August 29, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, August 29, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, February 28, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, February 28, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, February 28, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, April 3, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, April 3, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, April 3, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, June 29, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, December 4, 2023 | ASSIGNED TO LIE |
| Monday, December 4, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 4, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 2, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, February 6, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, January 17, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 6, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, April 2, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, September 30, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, September 30, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, September 30, 2024 | SOU EXTENSION 1 FILED |
| Monday, September 30, 2024 | SOU EXTENSION 1 GRANTED |